Showing results (2051-2060 of 2,897) with videos related to
Sort By:
Pageof 290
Molecular Diversity|March 8, 2024
Screening inhibitors against the Ef-Tu of Fusobacterium nucleatum: a docking, ADMET and PBPK assessment studyAhmad Alzamami, Norah A Alturki, Kanwal Khan, et al.Molecular Diversity|August 2, 2023
Cheminformatics and machine learning approaches for repurposing anti-viral compounds against monkeypox virus thymidylate kinaseAli A Rabaan, Ameen S S Alwashmi, Mutaib M Mashraqi, et al.Molecular Diversity|August 7, 2023
Identification of potent anti-immunogenic agents through virtual screening, 3D-QSAR studies, and in vitro experimentsMamona Mushtaq, Saman Usmani, Almas Jabeen, et al.Molecular Diversity|July 24, 2023
Exploration of the molecular mechanism of tea polyphenols against pulmonary hypertension by integrative approach of network pharmacology, molecular docking, and experimental verificationHuan Yang, Jun Cao, Jian-Min Li, et al.Molecular Diversity|July 22, 2023
In-vitro antiviral activity and in-silico targeted study of quinoline-3-carboxylate derivatives against SARS-Cov-2 isolateRavi Kumar Mittal, Priyank Purohit, Murugesan Sankaranarayanan, et al.Molecular Diversity|March 29, 2026
Managing Malassezia species and related infections: new insights into recent natural and synthetic antifungal compounds and their mechanism of actionDamiano Iacovozzi, Simone Carradori, Amar Osmanović, et al.Molecular Diversity|March 29, 2026
Targeting Als3 adhesin of clinically relevant Candida species using natural carotenoids: an in-silico studyZiyad Abdelaal, Bharath Reddy Boya, Jin-Hyung Lee, et al.Molecular Diversity|April 10, 2026
Network pharmacology, molecular docking, and In Vitro evaluation of morin against gastric cancerNilesh Naskar, Sunil Kumar, Deepanshu Mamgai, et al.Molecular Diversity|April 12, 2026
A label-free cell-based screening identifies enhydrin as a novel natural antagonist of the histamine H1 receptorZiwei Zhang, Qichao Hu, Hanzhen Wang, et al.Molecular Diversity|April 1, 2026
Rapid screening of potent and mechanistically insightful repurposable anticancer drugs targeting EGFR for non-small cell lung cancer: machine learning-aided and structure-guided approachMd Shakil Ahamed, Sheikh Abdullah Al AshikPageof 290